Nationally:
Males:
Cancer is by far the greatest contributor to excess mortality amongst men in Newcastle, accounting for one-third (32%) of the gap in male life expectancy. Premature deaths from lung Cancer account for 17.5% of the gap.
Females:
Cancer is the greatest contributor to excess mortality amongst women in Newcastle, accounting for 30% of the gap in female life expectancy. Premature deaths from lung cancer account for 24.7% of the gap.
Progress on the national health inequalities target for cancer
Nationally:
Locally:
Mortality from all cancers


Nationally:
Locally:
Locally:
Earlier diagnosis - screening
Cervical Cancer Screening
The effectiveness of the cervical screening programme is judged by its coverage. Coverage is defined as the percentage of women in a population eligible for screening who have been screened in the previous five years.
Nationally:
Locally:
Breast cancer screening
There are two indicators used in the breast screening programme - Coverage and Uptake.
Coverage is defined as the proportion of eligible women area who have had a test with a recorded result at least once in the previous 3 years. Currently coverage is best assessed using the 53-64 age group as women may be invited for screening at any time between their 50th and 53rd birthdays.
Locally:
Uptake is the proportion of women invited for screening, for whom a screening test result is recorded.
Nationally:
Locally:
Bowel cancer screening
Nationally:
Locally:
Earlier diagnosis - reduced waiting times
Nationally:
Locally:
Treatment
Locally:
End of Life Care
Nationally:
Locally:
Locally:
Our Vision is taken primarily from the North East's Strategy for health and well-being - Better Health, Fairer Health: A Strategy for 21st Century Health and Well-being in the North East of England which was launched in February 2008. The vision statements which are most relevant in relation to cancer are:
Newcastle's Health Improvement Strategy, in relation to cancer, sets out a vision for Newcastle in 2017 where:
The NHS North of Tyne Draft Strategic Plan has the following goal:
Goal 12: We will prevent avoidable premature deaths
In Newcastle and North Tyneside there is a higher rate than the England average of mortality from cardiovascular disease and cancer, much of which could be prevented or ameliorated. Screening for asymptomatic disease; identifying, managing and treating risk factors; and educating patients and professionals about the early presentation of disease, will require considerable targeted investment.
Metrics: [implementation plan and targets under development]
% reduction in <75 cancer mortality rate
Prevention remains the best form of tackling cancer, reducing the human suffering caused by the disease and improving outcomes. There is also a strong economic case for investing more in prevention, therefore reducing the pressure on services in the long term.
Reducing smoking prevalence
Smoking is the single largest preventable risk factor for cancer. See the smoking section for further details of reducing smoking prevalence in Newcastle.
Healthier nutrition / Increasing physical activity
The evidence linking poor diet and obesity to cancer has become much stronger. Locally we have an obesity strategy and the action plan is in the process of being refreshed. The action plan links with the Healthy Schools Awards and the Personal Health and Social Education (PHSE) curriculum and includes:
Alcohol
Excessive alcohol consumption is strongly linked to an increased risk of several cancers. In Newcastle a draft strategy is currently undergoing public consultation and responses will be used to develop detailed action plans. The strategies aim to promote sensible drinking and to reduce the impact of alcohol misuse. See the alcohol section for further details of reducing alcohol consumption in Newcastle.
Human Papilloma Virus (HPV) vaccination for cervical cancer
Vaccination now presents a further opportunity in cancer prevention, specifically for cervical cancer. The government has introduced a national vaccination programme for young girls against the human papillomavirus. This will protect against the strains of the virus which cause around seven out of ten cases of cervical cancer.
A specification is currently in development for the implementation of the HPV vaccination programme from Autumn 2008 in the North of Tyne area.
Increasing awareness and earlier presentation
Healthy Communities Collaborative Cancer project
A two-year community-based cancer initiative was launched in mid-2007. The Healthy Communities Collaborative aims to raise awareness and promote the earlier presentation of cancer symptoms. The project is focusing on three areas that have a high incidence of cancer, high death rates and poor survival rates - Walker, Byker and Elswick. The focus is on breast, bowel and lung cancer. The aims of the collaborative are to reduce health inequalities by working specifically with disadvantaged populations. The project is subject to on-going evaluation.
Social Marketing
THE North East's Strategy for Health and Wellbeing promises that a sustained social marketing campaign to promote cancer awareness in the North East will be undertaken.
Earlier diagnosis - Increasing the coverage/uptake of cancer screening
Cervical cancer screening
A key objective for the Newcastle Public Health team in reducing health inequalities is to improve cervical and breast screening uptake in Newcastle, focusing particularly on practices with low rates. Data has been analysed by Practice and is being used to design appropriate and culturally acceptable measures to improve screening coverage in targeted areas. Screening rates will also be monitored over time with shared learning from a range of initiatives.
Breast Screening
The Cancer Reform Strategy will have major implications on the delivery of the service. The planned expansion of the programme and the move to digitalised mammography will have workforce and funding implications. The PCT's Plan has prioritised some additional investment for the Breast Screening Unit to increase its capacity. As described under the plans for increasing cervical screening coverage, similar initiatives will be undertaken in relation to breast screening. The Healthy Communities Collaborative is providing an additional opportunity to engage with communities, raise awareness of breast cancer and promote screening in targeted areas.
Bowel cancer
The progress of this new programme will be monitored by a BCSP steering group, which currently meets at two monthly intervals.
Improving treatment
Key actions for 2008/09 (from Annual Operational Plan)
Improving End of Life Care
Specialist Palliative Care teams across North of Tyne have been leading developments in relation to improving standards of end of life care in the care home setting, with the key focus being on education and development of care home staff, building competencies and capabilities to deliver high quality end of life care across all long term conditions.
In relation to both End of Life Care and care for those who have survived cancer, work to implement the Cancer Reform Strategy will be taken forward by PCT commissioners in collaboration with Practice Based Commissioning (PBC) Groups.
Delivering Choice Programme
Tyneside has been selected as a site in the Marie Curie Delivering Choice Programme, a palliative care initiative that helps patients with terminal illnesses to make choices over their place of care and death. The three year project which begins in September 2008 will review all models of current service provision and make recommendations on alternative models of care / commissioning arrangements to bring care closer to home.
Improving the patient experience
Work to implement robust systems to ensure that patients experience good continuity of care and that psychological support services are available to cancer patients and their families has been ongoing in NECN over the past two years but further action is required to ensure that the needs of patients are met.
There are plans to carry out a patient satisfaction survey across the network.
Strengthening commissioning
Cancer services across the North of Tyne are planned through two structures:
There is a hospital trust locality group for Newcastle Hospitals and this acts as a multi-disciplinary forum bringing together the different professions involved in cancer as well as user and carer representation to inform service planning. In light of the Cancer Reform Strategy there is now a need to re-focus the work of the locality group so as to strengthen the role of Primary Care in commissioning. Discussions from the locality group is fed to the NECN commissioning group through the PCO commissioning representative. The Network commissioning group agrees priorities for investment, undertakes performance management and facilitates co-ordination between PCOs and the network.
Statement of resources and investment
Expenditure and Outcomes for Cancer
In mid-2007, an exercise was undertaken across the three North of Tyne PCOs, which compared health expenditure and outcomes across a range of programmes including cancer. National programme budgeting data for 2005-06 was analysed alongside QOF data and the data from the National Centre for Health Outcomes Development (NCHOD).
The outcome variables used in the analysis of Cancer programmes are listed below:

The results of the analysis for Newcastle were: High Cost: Poor Outcomes
It is important to attach a 'health warning' to the analysis undertaken and the conclusions reached, and to emphasise that this was only the first step in a process of investigation. The routinely available data identified what appear to be relatively high spending programme areas, relatively low spending areas, relatively low performing areas, and relatively inefficient areas. However, there are several possible explanations for these findings including errors in the data and differences in the way different PCTs have calculated programme expenditure.
As Newcastle appears to be relatively high spending PCT with relatively poor outcomes cancer programmes have been identified as one of the top priorities for further in-depth investigation. This work, which will focus specifically on lung cancer, will be undertaken during 2008 and will influence service developments from 2009 onwards. This investigation will incorporate the views of key stakeholders including patients, service users, carers and the public. The conclusions and recommendations arising from this work will be a key component of our 3-5 year commissioning strategy.
Funding / Investment on prevention / early detection
